Drug intelligence / Profile preview

Passion

Development stage: Unknown
Lead developer: Dosist
Modality: Small Molecules
Administration: Inhalation

Overview

Passion is one of six targeted cannabis formulas developed by dosist, a wellness company specializing in dose-controlled cannabis products. It is designed for use with dosist's vaporizer pens and is distributed by Surterra Wellness in the Florida medical cannabis market. The product aims to provide specific wellness effects.

Brand names: Passion

Targets

CNR1 (Cannabinoid receptor 1)CB1–CB2 (CB1–CB2 heteromer)GABAA (Gamma-aminobutyric acid receptor)

Beyond the preview

Go deeper on Passion.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Passion.

Explore the full profile